Clinical Trial Update: Different Doses of Naronapride vs. Placebo in Gastroparesis [Phase 2]

View source ↗

Summary

This Phase 2 study update reports results for different doses of naronapride versus placebo in patients with gastroparesis, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• Naronapride (naronapride)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED